Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 17 | 2024 | 61 | 4.460 |
Why?
|
| Nutrition Surveys | 12 | 2025 | 142 | 2.330 |
Why?
|
| Olfaction Disorders | 5 | 2021 | 15 | 1.900 |
Why?
|
| Auditory Threshold | 4 | 2025 | 29 | 1.700 |
Why?
|
| Health Surveys | 6 | 2016 | 313 | 1.210 |
Why?
|
| HIV Infections | 14 | 2023 | 965 | 1.140 |
Why?
|
| Hearing Loss, Noise-Induced | 2 | 2025 | 7 | 1.060 |
Why?
|
| Noise, Occupational | 2 | 2025 | 13 | 1.060 |
Why?
|
| Otitis Media | 3 | 2016 | 13 | 1.060 |
Why?
|
| Occupational Diseases | 2 | 2025 | 265 | 0.900 |
Why?
|
| Prevalence | 21 | 2019 | 1363 | 0.800 |
Why?
|
| Hearing Disorders | 5 | 2015 | 10 | 0.700 |
Why?
|
| Feeding Behavior | 1 | 2021 | 257 | 0.650 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2021 | 157 | 0.580 |
Why?
|
| United States | 23 | 2025 | 7949 | 0.570 |
Why?
|
| Gasoline | 1 | 2017 | 4 | 0.570 |
Why?
|
| Female | 47 | 2025 | 32755 | 0.530 |
Why?
|
| Infectious Disease Transmission, Vertical | 6 | 2023 | 76 | 0.530 |
Why?
|
| Tinnitus | 2 | 2016 | 19 | 0.520 |
Why?
|
| Middle Ear Ventilation | 1 | 2016 | 5 | 0.520 |
Why?
|
| Pregnancy Complications, Infectious | 5 | 2023 | 65 | 0.520 |
Why?
|
| Humans | 56 | 2025 | 63051 | 0.490 |
Why?
|
| Taste | 3 | 2021 | 36 | 0.480 |
Why?
|
| Adult | 29 | 2025 | 16658 | 0.480 |
Why?
|
| Male | 41 | 2025 | 29773 | 0.470 |
Why?
|
| Child | 17 | 2023 | 4479 | 0.440 |
Why?
|
| Smell | 2 | 2015 | 28 | 0.440 |
Why?
|
| Aged | 24 | 2025 | 14268 | 0.430 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 4 | 2021 | 7 | 0.430 |
Why?
|
| Population Surveillance | 2 | 2018 | 204 | 0.430 |
Why?
|
| Middle Aged | 23 | 2025 | 17605 | 0.410 |
Why?
|
| Vertigo | 3 | 2019 | 20 | 0.400 |
Why?
|
| Young Adult | 13 | 2025 | 4646 | 0.400 |
Why?
|
| Self Report | 3 | 2021 | 371 | 0.390 |
Why?
|
| Presbycusis | 1 | 2012 | 6 | 0.390 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 138 | 0.390 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 349 | 0.380 |
Why?
|
| Income | 3 | 2024 | 169 | 0.370 |
Why?
|
| Risk Factors | 19 | 2019 | 5297 | 0.370 |
Why?
|
| Adolescent | 17 | 2023 | 6189 | 0.360 |
Why?
|
| Anti-Retroviral Agents | 4 | 2023 | 76 | 0.330 |
Why?
|
| Hearing | 4 | 2023 | 34 | 0.330 |
Why?
|
| Sensation Disorders | 3 | 2016 | 21 | 0.330 |
Why?
|
| Cigarette Smoking | 2 | 2021 | 57 | 0.320 |
Why?
|
| Taste Disorders | 1 | 2009 | 1 | 0.320 |
Why?
|
| Developmental Disabilities | 3 | 2019 | 112 | 0.320 |
Why?
|
| Audiometry | 6 | 2016 | 21 | 0.320 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 154 | 0.320 |
Why?
|
| Epidemiologic Studies | 1 | 2009 | 34 | 0.310 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2020 | 48 | 0.310 |
Why?
|
| Infant | 7 | 2021 | 1629 | 0.310 |
Why?
|
| Audiometry, Pure-Tone | 6 | 2024 | 31 | 0.300 |
Why?
|
| Pregnancy | 9 | 2023 | 2319 | 0.270 |
Why?
|
| Child, Preschool | 8 | 2023 | 1969 | 0.270 |
Why?
|
| Speech Perception | 2 | 2020 | 79 | 0.270 |
Why?
|
| Longitudinal Studies | 7 | 2024 | 1243 | 0.260 |
Why?
|
| Cohort Studies | 8 | 2024 | 2763 | 0.260 |
Why?
|
| Cognition Disorders | 2 | 2019 | 220 | 0.250 |
Why?
|
| Dizziness | 2 | 2016 | 18 | 0.250 |
Why?
|
| Language Development Disorders | 2 | 2018 | 27 | 0.250 |
Why?
|
| Norway | 4 | 2024 | 23 | 0.240 |
Why?
|
| Surveys and Questionnaires | 7 | 2022 | 2642 | 0.240 |
Why?
|
| Otitis Media with Effusion | 2 | 2016 | 10 | 0.230 |
Why?
|
| Otitis Media, Suppurative | 2 | 2015 | 3 | 0.230 |
Why?
|
| Postural Balance | 3 | 2016 | 65 | 0.230 |
Why?
|
| Language Disorders | 2 | 2016 | 25 | 0.230 |
Why?
|
| Reference Values | 1 | 2025 | 337 | 0.220 |
Why?
|
| Vision Disorders | 3 | 2015 | 64 | 0.210 |
Why?
|
| Logistic Models | 5 | 2019 | 1272 | 0.200 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 2 | 2021 | 9 | 0.200 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 5410 | 0.200 |
Why?
|
| Disability Evaluation | 2 | 2019 | 214 | 0.170 |
Why?
|
| Chronic Disease | 4 | 2019 | 751 | 0.170 |
Why?
|
| Caloric Tests | 1 | 2020 | 1 | 0.170 |
Why?
|
| Ocular Motility Disorders | 1 | 2020 | 2 | 0.170 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2020 | 3 | 0.170 |
Why?
|
| Vestibular Diseases | 1 | 2020 | 9 | 0.160 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 2556 | 0.160 |
Why?
|
| Noise | 1 | 2020 | 33 | 0.160 |
Why?
|
| International Classification of Functioning, Disability and Health | 1 | 2019 | 6 | 0.160 |
Why?
|
| World Health Organization | 1 | 2019 | 34 | 0.160 |
Why?
|
| HIV Seronegativity | 2 | 2019 | 19 | 0.160 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 933 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2019 | 37 | 0.160 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 66 | 0.160 |
Why?
|
| Sex Distribution | 3 | 2016 | 251 | 0.160 |
Why?
|
| Japan | 1 | 2018 | 59 | 0.150 |
Why?
|
| Infant, Newborn | 3 | 2019 | 1347 | 0.150 |
Why?
|
| Smoke | 1 | 2018 | 24 | 0.150 |
Why?
|
| Global Health | 1 | 2019 | 181 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 158 | 0.150 |
Why?
|
| Voice Disorders | 1 | 2016 | 5 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2024 | 1113 | 0.130 |
Why?
|
| Audiometry, Speech | 1 | 2016 | 5 | 0.130 |
Why?
|
| HIV | 2 | 2018 | 70 | 0.130 |
Why?
|
| Sex Factors | 5 | 2019 | 972 | 0.120 |
Why?
|
| Exfoliation Syndrome | 1 | 2015 | 9 | 0.120 |
Why?
|
| Prospective Studies | 7 | 2018 | 3257 | 0.120 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2016 | 28 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 331 | 0.120 |
Why?
|
| Urban Health | 1 | 2015 | 40 | 0.120 |
Why?
|
| Correction of Hearing Impairment | 1 | 2015 | 3 | 0.120 |
Why?
|
| Hearing Loss, High-Frequency | 1 | 2015 | 3 | 0.120 |
Why?
|
| Arthritis | 1 | 2015 | 53 | 0.120 |
Why?
|
| Hearing Aids | 1 | 2015 | 6 | 0.120 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2015 | 47 | 0.120 |
Why?
|
| Health Promotion | 1 | 2019 | 492 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 772 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2016 | 150 | 0.120 |
Why?
|
| Bottle Feeding | 1 | 2014 | 5 | 0.120 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 84 | 0.110 |
Why?
|
| Ear Diseases | 1 | 2014 | 12 | 0.110 |
Why?
|
| Recurrence | 1 | 2016 | 635 | 0.110 |
Why?
|
| Acute Disease | 1 | 2016 | 669 | 0.110 |
Why?
|
| Cochlea | 1 | 2014 | 22 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 88 | 0.110 |
Why?
|
| Vision, Ocular | 1 | 2013 | 20 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 294 | 0.110 |
Why?
|
| Age Factors | 5 | 2019 | 1555 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2016 | 314 | 0.100 |
Why?
|
| Canada | 1 | 2013 | 153 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2013 | 74 | 0.100 |
Why?
|
| Developing Countries | 1 | 2013 | 94 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2014 | 148 | 0.100 |
Why?
|
| Language Tests | 1 | 2012 | 39 | 0.090 |
Why?
|
| Quality of Life | 1 | 2019 | 1220 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 258 | 0.090 |
Why?
|
| Maternal Age | 2 | 2019 | 34 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 458 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2011 | 106 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2010 | 28 | 0.080 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 537 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2016 | 496 | 0.080 |
Why?
|
| Iceland | 3 | 2015 | 8 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2023 | 988 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2015 | 754 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2018 | 6558 | 0.070 |
Why?
|
| Depression | 1 | 2014 | 883 | 0.070 |
Why?
|
| Geriatrics | 1 | 2007 | 42 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 166 | 0.060 |
Why?
|
| Environment | 1 | 2007 | 122 | 0.060 |
Why?
|
| Aging | 2 | 2015 | 742 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2018 | 2048 | 0.060 |
Why?
|
| Puerto Rico | 2 | 2019 | 132 | 0.060 |
Why?
|
| Mass Screening | 1 | 2010 | 687 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 665 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2007 | 382 | 0.060 |
Why?
|
| Maternal Exposure | 1 | 2004 | 41 | 0.060 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2004 | 40 | 0.060 |
Why?
|
| Cognition | 2 | 2020 | 481 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2004 | 94 | 0.050 |
Why?
|
| Phenotype | 1 | 2007 | 1195 | 0.050 |
Why?
|
| Beds | 1 | 2003 | 10 | 0.050 |
Why?
|
| Mother-Child Relations | 1 | 2003 | 46 | 0.050 |
Why?
|
| Nonlinear Dynamics | 1 | 2022 | 25 | 0.050 |
Why?
|
| Menthol | 1 | 2021 | 6 | 0.050 |
Why?
|
| Birth Weight | 2 | 2016 | 85 | 0.040 |
Why?
|
| Tobacco Products | 1 | 2021 | 80 | 0.040 |
Why?
|
| Vestibular Function Tests | 1 | 2020 | 4 | 0.040 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 54 | 0.040 |
Why?
|
| Metabolism | 1 | 2019 | 13 | 0.040 |
Why?
|
| Sleep | 1 | 2003 | 225 | 0.040 |
Why?
|
| Missouri | 1 | 2019 | 10 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 95 | 0.040 |
Why?
|
| Academic Success | 1 | 2019 | 12 | 0.040 |
Why?
|
| Infant Health | 1 | 2019 | 3 | 0.040 |
Why?
|
| Anthropometry | 1 | 2019 | 87 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1541 | 0.040 |
Why?
|
| Data Collection | 2 | 2016 | 383 | 0.040 |
Why?
|
| Child Health | 1 | 2019 | 31 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 91 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2018 | 44 | 0.040 |
Why?
|
| Speech | 1 | 2018 | 62 | 0.040 |
Why?
|
| Lipids | 1 | 2019 | 316 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2019 | 483 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1112 | 0.030 |
Why?
|
| Polysomnography | 1 | 2016 | 54 | 0.030 |
Why?
|
| Visual Field Tests | 1 | 2015 | 24 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 860 | 0.030 |
Why?
|
| Central America | 1 | 2015 | 2 | 0.030 |
Why?
|
| West Indies | 1 | 2015 | 6 | 0.030 |
Why?
|
| Visual Fields | 1 | 2015 | 49 | 0.030 |
Why?
|
| South America | 1 | 2015 | 26 | 0.030 |
Why?
|
| Early Medical Intervention | 1 | 2015 | 19 | 0.030 |
Why?
|
| Mexico | 1 | 2015 | 39 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2015 | 73 | 0.030 |
Why?
|
| Confusion | 1 | 2015 | 17 | 0.030 |
Why?
|
| Urban Population | 1 | 2016 | 190 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2015 | 24 | 0.030 |
Why?
|
| Social Class | 1 | 2016 | 132 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 1074 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2015 | 50 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 390 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2446 | 0.030 |
Why?
|
| Psychometrics | 1 | 2016 | 377 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5597 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 30 | 0.030 |
Why?
|
| Walking | 1 | 2016 | 237 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 91 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 528 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 421 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 192 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2015 | 140 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2014 | 176 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 768 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2015 | 285 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 419 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 346 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 607 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 802 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 943 | 0.020 |
Why?
|
| Cause of Death | 1 | 2013 | 437 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2007 | 92 | 0.020 |
Why?
|
| Body Composition | 1 | 2007 | 151 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2007 | 109 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 3744 | 0.020 |
Why?
|
| Body Height | 1 | 2004 | 68 | 0.010 |
Why?
|
| Dementia | 1 | 2007 | 258 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2003 | 241 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 271 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 831 | 0.010 |
Why?
|